Physician profile
Christopher Geier
NPI 1255362703
$1,124.97
in general payments reported to CMS, 2019-2025
9 companies · $520 in 2025
The $520 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.25 · 2023: $230 · 2024: $354 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $337.95 | 2023-2025 | Monovisc, Orthovisc, Dynacord |
| Bioventus LLC | $312.05 | 2023-2025 | Durolane, Xcell, Durolane |
| Smith+Nephew, INC. | $197.64 | 2023-2025 | Tandem, Aetos Shoulder System, Evos |
| Ferring Pharmaceuticals INC. | $94.48 | 2023-2025 | Euflexxa |
| Stryker Corporation | $86.24 | 2024 | Insignia |
| Davol INC. | $35.39 | 2025 | Arista |
| Vertex Pharmaceuticals Incorporated | $25.99 | 2025 | |
| Boston Scientific Corporation | $21.25 | 2022 | |
| Painteq LLC | $13.98 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Geier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.